- $47.90m
- -$88.25m
- $0.80m
Brief: Ikena Oncology Reports Second Quarter 2021 Financial Results And Provides Update On Key Programs
Ikena Oncology Inc expected to post a loss of 36 cents a share - Earnings Preview
NASDAQ RESUMED AT 10:06 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Ikena Oncology Inc reports results for the quarter ended in March - Earnings Summary
Brief: Ikena Oncology Reports Q1 Loss Per Share Of $2.52
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:44 AM
Ikena Oncology: Soars in Nasdaq debut
NASDAQ RESUMED AT 03:15 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:35 PM
NASDAQ RESUMED AT 02:29 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:21 PM
NASDAQ RESUMED AT 02:08 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:03 PM
NASDAQ RESUMED AT 11:14 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:09 AM
NASDAQ RESUMED AT 11:05 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:00 AM
NASDAQ RESUMED AT 10:23 AM